These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15613111)

  • 21. Graves disease associated with autoimmune thrombocytopenic purpura.
    Hofbauer LC; Spitzweg C; Schmauss S; Heufelder AE
    Arch Intern Med; 1997 May; 157(9):1033-6. PubMed ID: 9140276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' disease-induced immune thrombocytopenic purpura in an African female: a case report.
    Agyapong KO; Folson AA; Fiador K; Kootin-Sanwu C; Tufuor M; Bampoh SA; Fiscian H; Wonkyi R
    J Med Case Rep; 2023 Apr; 17(1):122. PubMed ID: 37016396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G; Jie Y; Situ Y
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Graves' disease on idiopathic thrombocytopenic purpura.
    Resnitzky P; Schonfeld S; Dassa H
    Arch Intern Med; 1979 Apr; 139(4):483-4. PubMed ID: 86327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Graves' disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases].
    Cohen Aubart F; Jublanc C; Bruckert E
    Ann Endocrinol (Paris); 2007 Feb; 68(1):55-7. PubMed ID: 17292844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy.
    Sugimoto K; Sasaki M; Isobe Y; Tamayose K; Hieda M; Oshimi K
    Eur J Haematol; 2005 Jan; 74(1):73-4. PubMed ID: 15613111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evans' syndrome associated with Graves' disease.
    Yashiro M; Nagoshi H; Kasuga Y; Isobe H; Kitajima S; Nakagawa T; Ohshima J; Ide K; Someya K; Saito N
    Intern Med; 1996 Dec; 35(12):987-90. PubMed ID: 9031001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Subclinical hyperthyroidism/thyrotoxicosis].
    Takasu N
    Nihon Rinsho; 2006 May; Suppl 1():258-64. PubMed ID: 16776140
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic idiopathic thrombocytopenic purpura].
    Treppendahl MB; Nielsen OJ
    Ugeskr Laeger; 2004 Sep; 166(39):3389-93. PubMed ID: 15515391
    [No Abstract]   [Full Text] [Related]  

  • 31. Childhood thrombocytopenic purpura--review and a case report.
    Reddy VV; Rawal YB
    Indian J Dent Res; 1996; 7(3):103-6. PubMed ID: 9495125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graves' hyperthyroidism-related pancytopenia: a case report with literature review.
    Scappaticcio L; Bellastella G; Maiorino MI; Longo M; Catalano C; Esposito K; Paolisso G; Rizzo MR
    Hormones (Athens); 2021 Mar; 20(1):93-100. PubMed ID: 32638234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early-onset hyperthyroidism with muscle involvement: a report on a patient].
    Greco F; Caruso M; Falsaperla R; Fiumara A; Parano E
    Pediatr Med Chir; 1996; 18(6):611-3. PubMed ID: 9173411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithyroid arthritis syndrome.
    Bajaj S; Bell MJ; Shumak S; Briones-Urbina R
    J Rheumatol; 1998 Jun; 25(6):1235-9. PubMed ID: 9632094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pros and cons of drug therapy for immune thrombocytopenic purpura in children.
    Tarantino MD; Buchanan GR
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1301-14, viii. PubMed ID: 15511617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascorbic acid as first-line therapy in immune thrombocytopenic purpura.
    Rossi V; Masi M; Di Macco E; Papa G
    Haematologica; 1991; 76(5):438-9. PubMed ID: 1806452
    [No Abstract]   [Full Text] [Related]  

  • 37. Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.
    Tabata R; Tabata C; Tazoh A; Nagai T
    Int Immunopharmacol; 2012 Jul; 13(3):242-4. PubMed ID: 22561120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ophthalmologic changes in hyperthyroidism].
    Hagert M
    Z Gesamte Inn Med; 1971 Aug; 26(16):501-8. PubMed ID: 4110417
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.